Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ischemic Heart Disease

Free Subscription 02.06.2025 2 Am Heart J 3 Am J Cardiol 1 Angiology 1 Atherosclerosis 2 BMJ 2 Cardiovasc Res 1 Catheter Cardiovasc Interv 3 Circ Cardiovasc Interv 1 Circ Cardiovasc Qual Outcomes 1 Circulation 1 Heart 4 Int J Cardiol 2 J Am Coll Cardiol 1 J Thorac Cardiovasc Surg 1 Mol Cell Biochem 8 N Engl J Med 5 PLoS One 1 Thromb Haemost

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. FEISTRITZER HJ, Jobs A, Zeymer U, Schneider S, et al
   Complete revascularization versus culprit-lesion only PCI in patients with NSTEMI and multivessel disease - Design and rationale of the randomized COMPLETE-NSTEMI trial.
   Am Heart J. 2025;287:94-106.
   PubMed         Abstract available
   
   
2. MAINI AS, Abu-Much A, Redfors B, Wollmuth JR, et al
   Outcomes Among Patients with Coronary Bifurcation Lesions Undergoing Impella-Supported High-Risk Percutaneous Coronary Intervention.
   Am Heart J. 2025 May 22:S0002-8703(25)00176-0. doi: 10.1016/j.ahj.2025.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

3. CYON L, Kadesjo E, Roos A
   Prognostic Implications Of High-Sensitivity Cardiac Troponins In Patients With Acute Kidney Injury Without Myocardial Infarction.
   Am J Cardiol. 2025 May 22:S0002-9149(25)00329.
   PubMed         Abstract available
   
   
4. PODOLECKI T, Kalarus Z, Kowalczyk J
   Inflammation - still an underestimated player in coronary artery disease.
   Am J Cardiol. 2025 May 23:S0002-9149(25)00331.
   PubMed        
   
   
5. GATTONI C, Bebe K, Bross R, Wang C, et al
   Vigorous But Not Moderate Physical Activity Is Associated With Reduced Cardiovascular Disease Risk In Young Hispanic Men.
   Am J Cardiol. 2025 May 21:S0002-9149(25)00328.
   PubMed         Abstract available
   
   

   
   Angiology

6. SIBEL ?
   Letter: "Structural Abnormalities of the Achilles Tendon are Associated With Coronary Artery Disease Even Without Achilles Tendon Thickening".
   Angiology. 2025 May 28:33197251341753. doi: 10.1177/00033197251341753.
   PubMed        
   
   

   
   Atherosclerosis

7. FUJIMOTO D, Kinoshita D, Suzuki K, Niida T, et al
   Coronary spotty calcification, compared with macro calcification, is associated with a higher level of vascular inflammation and plaque vulnerability in patients with stable angina.
   Atherosclerosis. 2025;405:119237.
   PubMed         Abstract available
   
   

   
   BMJ

8. ZHANG X, Wang S, Zhou X, Tang Y, et al
   A village doctor-led mobile health intervention for cardiovascular risk reduction in rural China: cluster randomised controlled trial.
   BMJ. 2025;389:e082765.
   PubMed         Abstract available
   
   
9. JANSEN C, van der Palen J, Tabak M
   Using mobile health to reduce cardiovascular disease risk.
   BMJ. 2025;389:r972.
   PubMed        
   
   

   
   Cardiovasc Res

10. CHEN Q, Yu Y, Tong L, Weiss RM, et al
    Targeted delivery of TAPI-1 via biomimetic nanoparticles ameliorates post-infarct left ventricle function and remodelling.
    Cardiovasc Res. 2025;121:760-774.
    PubMed         Abstract available
    
    
11. TALABIEKE S, Yang X, Yang J, Wan Q, et al
    Arachidonic acid synergizes with aspirin preventing myocardial ischaemia-reperfusion injury and mitigates bleeding risk.
    Cardiovasc Res. 2025;121:775-787.
    PubMed         Abstract available
    
    

    
    Catheter Cardiovasc Interv

12. MORI T, Aoyama H, Tanaka A, Kato K, et al
    Detailed Visualization of the Dissected False Lumen Using Intravascular Ultrasound, Optical Coherence Tomography, and Angioscopy in a Young Man With Acute Myocardial Infarction Caused by Spontaneous Coronary Artery Dissection.
    Catheter Cardiovasc Interv. 2025 May 28. doi: 10.1002/ccd.31639.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Interv

13. BROWN K, Xu K, Hahn RT, Pibarot P, et al
    Impact of Coronary Artery Disease on Cardiovascular Outcomes Differs Between Men and Women With Severe Aortic Stenosis.
    Circ Cardiovasc Interv. 2025 May 27:e014999.
    PubMed         Abstract available
    
    
14. MOVAHED MR
    Letter by Movahed Regarding Article, "Chronic Total Occlusion Percutaneous Coronary Intervention: Present and Future".
    Circ Cardiovasc Interv. 2025 May 30:e015552.
    PubMed        
    
    
15. TANNU M, Jones WS, Alexander JH, Mehran R, et al
    Ethical Considerations for Informed Consent in Acute Myocardial Infarction Clinical Trials.
    Circ Cardiovasc Interv. 2025 May 27:e015016.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Qual Outcomes

16. BREATHETT K, O'Brien EC, Allen N
    Cardiovascular Epidemiology: From Findings to Impact.
    Circ Cardiovasc Qual Outcomes. 2025 May 29:e012347.
    PubMed        
    
    

    
    Circulation

17. SCHNEEWEISS S, Kruger N
    Non-Randomized Database Analyses to Complement Randomized Clinical Trials: Promising Approaches for Cardiovascular Medicine.
    Circulation. 2025;151:1495-1497.
    PubMed        
    
    

    
    Heart

18. MITCHELL A, Watson MC, Welsh TJ, McGrogan A, et al
    Safety and effectiveness of anticoagulation therapy in older people with atrial fibrillation during exposed and unexposed treatment periods.
    Heart. 2025 Feb 17:heartjnl-2024-324763. doi: 10.1136/heartjnl-2024-324763.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

19. ZHANG X, Jin Q, Li C, Yang J, et al
    Prognostic value of angiography-derived microcirculatory resistance in patients undergoing rotational atherectomy- a multi-center study.
    Int J Cardiol. 2025;434:133322.
    PubMed         Abstract available
    
    
20. FERRI N
    "SES", "SESS", or "SVESS" approaches for patients with myocardial infarction.
    Int J Cardiol. 2025;435:133412.
    PubMed        
    
    
21. GIALLAURIA F, Vigorito C
    Editorial to "Impact of Frailty Assessment on Outcomes in Critical Acute Myocardial Infarction: Insights from the Hospital Frailty Risk Measure (HFRM)", Wu et al., Int J Cardiol. 2025 Apr 22:133294. doi: 10.1016/j.ijcard.2025.133294. Epub ahead of pri
    Int J Cardiol. 2025;435:133418.
    PubMed        
    
    
22. AHMAD MH, Bilal M, Ibrahim M, Iman H, et al
    Letter to editor on low chronotropic response in post-myocardial infarction exercise test predicts worse prognosis in patients with preserved or mildly reduced left ventricular ejection fraction.
    Int J Cardiol. 2025 May 27:133432. doi: 10.1016/j.ijcard.2025.133432.
    PubMed        
    
    

    
    J Am Coll Cardiol

23. BARKAS F, Brandts J, De Bacquer D, Jennings C, et al
    Global Variation in Lipoprotein(a) Levels Among Patients With Coronary Heart Disease: Insights From the INTERASPIRE Study and Implications for Emerging Lp(a)-Lowering Therapies.
    J Am Coll Cardiol. 2025;85:2028-2042.
    PubMed         Abstract available
    
    
24. ERLINGE D, Tsimikas S, Maeng M, Maehara A, et al
    Lipoprotein(a), Cholesterol, Triglyceride Levels, and Vulnerable Coronary Plaques: A PROSPECT II Substudy.
    J Am Coll Cardiol. 2025;85:2011-2024.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

25. NISIVACO S, Kitahara H, Bhasin R, Patel B, et al
    A decade of robotic beating-heart totally endoscopic coronary bypass (TECAB) at a single institution: Outcomes with 10-year follow-up.
    J Thorac Cardiovasc Surg. 2025;169:1753-1760.
    PubMed         Abstract available
    
    

    
    Mol Cell Biochem

26. WANG J, Zheng W, Shang H, Pan L, et al
    Radial artery intima-media thickening is a sensitive marker of atherosclerosis and coronary artery stenosis, a lesson from a 6-year study of a spontaneous monkey model.
    Mol Cell Biochem. 2025 May 24. doi: 10.1007/s11010-025-05315.
    PubMed         Abstract available
    
    

    
    N Engl J Med

27. ZANNAD F
    Seeking Multiorgan Benefits with Cardiovascular-Kidney-Metabolic Drug Therapy.
    N Engl J Med. 2025;392:2061-2062.
    PubMed        
    
    
28. STRIESSNIG J
    Colchicine and Spironolactone in Acute Myocardial Infarction.
    N Engl J Med. 2025;392:2071-2072.
    PubMed        
    
    
29. VAN TWIST DJL, Appelboom Y
    Colchicine and Spironolactone in Acute Myocardial Infarction.
    N Engl J Med. 2025;392:2072.
    PubMed        
    
    
30. GU HQ, Jiang Y, Li H
    Colchicine and Spironolactone in Acute Myocardial Infarction.
    N Engl J Med. 2025;392:2072-2073.
    PubMed        
    
    
31. KIDA Y
    Colchicine and Spironolactone in Acute Myocardial Infarction.
    N Engl J Med. 2025;392:2073.
    PubMed        
    
    
32. GOLINO M, Van Tassell B, Abbate A
    Colchicine and Spironolactone in Acute Myocardial Infarction.
    N Engl J Med. 2025;392:2073-2074.
    PubMed        
    
    
33. JOLLY SS, d'Entremont MA, Lee SF
    Colchicine and Spironolactone in Acute Myocardial Infarction. Reply.
    N Engl J Med. 2025;392:2074-2075.
    PubMed        
    
    
34. JOLLY SS, d'Entremont MA, Mian R
    Colchicine and Spironolactone in Acute Myocardial Infarction. Reply.
    N Engl J Med. 2025;392:2075.
    PubMed        
    
    

    
    PLoS One

35. NORDENSKJOLD AM, Lindhagen L, Wettermark B, Lindahl B, et al
    Impact of persistence to secondary preventive medication on prognosis for patients with myocardial infarction with and without obstructive coronary arteries.
    PLoS One. 2025;20:e0324533.
    PubMed         Abstract available
    
    
36. PAL E, Shokoples B, Naik S, Hogue K, et al
    A surgical recovery matrix to evaluate post-surgical recovery in mice using sham and myocardial infarction models of cardiac surgery as prototypes.
    PLoS One. 2025;20:e0323317.
    PubMed         Abstract available
    
    
37. ZHOU S, Qiu M, Wang K, Duan Y, et al
    Association of high-sensitivity C-reactive protein to albumin ratio with all-cause and cardiac death in coronary heart disease individuals: A retrospective NHANES study.
    PLoS One. 2025;20:e0322281.
    PubMed         Abstract available
    
    
38. KIM M, Lee K, Chae K, Jung CY, et al
    The effect of public reporting of acute myocardial infarction on the choice of hospital.
    PLoS One. 2025;20:e0323780.
    PubMed         Abstract available
    
    
39. NORDENSKJOLD AM, Qvarnstrom M, Wettermark B, Lindahl B, et al
    Adherence to secondary preventive treatment following myocardial infarction with and without obstructive coronary artery disease.
    PLoS One. 2025;20:e0324072.
    PubMed         Abstract available
    
    

    
    Thromb Haemost

40. LI J, Chen R, Zhao X, Liu C, et al
    Circulating and Regional Matrix Gla Protein Indicating Plaque Calcification and Prognosis of Patients with ST-Segment Elevation Myocardial Infarction.
    Thromb Haemost. 2025 May 23. doi: 10.1055/a-2599-9386.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.